Frank van Leth

Associate Professor Health Sciences

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile


Journal article


M. van der Valk, J. Kastelein, R. Murphy, F. van Leth, C. Katlama, A. Horban, M. Glesby, G. Behrens, B. Clotet, R. Stellato, H. Molhuizen, P. Reiss
AIDS (London), 2001

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
van der Valk, M., Kastelein, J., Murphy, R., van Leth, F., Katlama, C., Horban, A., … Reiss, P. (2001). Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile. AIDS (London).


Chicago/Turabian   Click to copy
Valk, M. van der, J. Kastelein, R. Murphy, F. van Leth, C. Katlama, A. Horban, M. Glesby, et al. “Nevirapine-Containing Antiretroviral Therapy in HIV-1 Infected Patients Results in an Anti-Atherogenic Lipid Profile.” AIDS (London) (2001).


MLA   Click to copy
van der Valk, M., et al. “Nevirapine-Containing Antiretroviral Therapy in HIV-1 Infected Patients Results in an Anti-Atherogenic Lipid Profile.” AIDS (London), 2001.


BibTeX   Click to copy

@article{m2001a,
  title = {Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile},
  year = {2001},
  journal = {AIDS (London)},
  author = {van der Valk, M. and Kastelein, J. and Murphy, R. and van Leth, F. and Katlama, C. and Horban, A. and Glesby, M. and Behrens, G. and Clotet, B. and Stellato, R. and Molhuizen, H. and Reiss, P.}
}